Treating people with IBS: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome (IBS)

Completed

• Conditions: Irritable Bowel Syndrome (IBS); Digestive System; Irritable bowel syndrome (IBS)

• Registration Number: ISRCTN67764449
• Lead Sponsor: niversity of East London (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-15
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Participants should be aged 18?65, should have been diagnosed as having IBS by a qualified medical practitioner, and should have diarrhoea as a main symptom.

Exclusion Criteria

Any other co-existing illnesses, and non-confirmation of the diagnosis by GP.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in daily ratings of seven symptoms of IBS (self report) above placebo level.

Secondary Outcome Measures

Name	Time	Method
Improvement in anxiety and depression ratings (self report) following experimental condition.